{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:44:49Z","timestamp":1767015889290},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,8]]},"DOI":"10.7759\/cureus.61944","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T12:13:24Z","timestamp":1717848804000},"source":"Crossref","is-referenced-by-count":2,"title":["Blastic Plasmacytoid Dendritic Cell Neoplasm Developed in Chronic Myeloid Leukemia in Molecular Remission During a Four-Year Treatment-Free Interval After Six Years of Dasatinib Treatment"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risen","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tanimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Blastic plasmacytoid dendritic cell neoplasm","author":"Facchetti F","year":"2017","unstructured":"Facchetti F, Petrella T, Pileri SA. Blastic plasmacytoid dendritic cell neoplasm. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al. (ed): International Agency for Research on Cancer Press, Lyon; 2017. 174-7."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.08.014","article-title":"Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm","volume":"73","author":"Guru Murthy GS","year":"2018","unstructured":"Guru Murthy GS, Pemmaraju N, Atallah E. Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm. Leuk Res. 2018, 73:21-3. 10.1016\/j.leukres.2018.08.014","journal-title":"Leuk Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard J","year":"2002","unstructured":"Feuillard J, Jacob MC, Valensi F, et al.. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002, 99:1556-63. 10.1182\/blood.v99.5.1556","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":"CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells","volume":"29","author":"Reichard KK","year":"2005","unstructured":"Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC, Larson RS. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol. 2005, 29:1274-83. 10.1097\/01.pas.0000172194.32918.5c","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.09.006","article-title":"Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group","volume":"34","author":"Tsagarakis NJ","year":"2010","unstructured":"Tsagarakis NJ, Kentrou NA, Papadimitriou KA, et al.. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res. 2010, 34:438-46. 10.1016\/j.leukres.2009.09.006","journal-title":"Leuk Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"Pagano L","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, et al.. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013, 98:239-46. 10.3324\/haematol.2012.072645","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950515)75:10<2474::aid-cncr2820751013>3.0.co;2-y","article-title":"Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents","volume":"75","author":"Brody JP","year":"1995","unstructured":"Brody JP, Allen S, Schulman P, et al.. Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer. 1995, 75:2474-83. 10.1002\/1097-0142(19950515)75:10&lt;2474::aid-cncr2820751013&gt;3.0.co;2-y","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199710000-00014","article-title":"Blastic natural killer cell leukemia\/lymphoma: a clinicopathologic study","volume":"21","author":"DiGiuseppe JA","year":"1997","unstructured":"DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, Borowitz MJ. Blastic natural killer cell leukemia\/lymphoma: a clinicopathologic study. Am J Surg Pathol. 1997, 21:1223-30. 10.1097\/00000478-199710000-00014","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200207000-00003","article-title":"'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella T","year":"2002","unstructured":"Petrella T, Comeau MR, Maynadi\u00e9 M, et al.. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002, 26:852-62. 10.1097\/00000478-200207000-00003","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06458.x","article-title":"Plasmacytoid dendritic cell leukaemia\/lymphoma: towards a well defined entity?","volume":"136","author":"Garnache-Ottou F","year":"2007","unstructured":"Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia\/lymphoma: towards a well defined entity?. Br J Haematol. 2007, 136:539-48. 10.1111\/j.1365-2141.2006.06458.x","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia F","year":"2014","unstructured":"Julia F, Dalle S, Duru G, et al.. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol. 2014, 38:673-80. 10.1097\/PAS.0000000000000156","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Garnache-Ottou F","year":"2009","unstructured":"Garnache-Ottou F, Feuillard J, Ferrand C, et al.. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol. 2009, 145:624-36. 10.1111\/j.1365-2141.2009.07679.x","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704215","article-title":"What is CD4+CD56+ malignancy and how should it be treated?","volume":"32","author":"Reimer P","year":"2003","unstructured":"Reimer P, R\u00fcdiger T, Kraemer D, et al.. What is CD4+CD56+ malignancy and how should it be treated?. Bone Marrow Transplant. 2003, 32:637-46. 10.1038\/sj.bmt.1704215","journal-title":"Bone Marrow Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621268","article-title":"Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm","volume":"125","author":"Aoki T","year":"2015","unstructured":"Aoki T, Suzuki R, Kuwatsuka Y, et al.. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm. Blood. 2015, 125:3559-62. 10.1182\/blood-2015-01-621268","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01478-5","article-title":"Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)","volume":"57","author":"Bashir Q","year":"2022","unstructured":"Bashir Q, Milton DR, Popat UR, et al.. Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). Bone Marrow Transplant. 2022, 57:51-6. 10.1038\/s41409-021-01478-5","journal-title":"Bone Marrow Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12412","article-title":"Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients","volume":"169","author":"Julia F","year":"2013","unstructured":"Julia F, Petrella T, Beylot-Barry M, et al.. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013, 169:579-86. 10.1111\/bjd.12412","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10489","article-title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia","volume":"94","author":"Khoury JD","year":"2002","unstructured":"Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002, 94:2401-8. 10.1002\/cncr.10489","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3297","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling M","year":"2003","unstructured":"Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003, 101:5007-9. 10.1182\/blood-2002-10-3297","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.101","article-title":"Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: a national database study","volume":"83","author":"Ramachandran V","year":"2020","unstructured":"Ramachandran V, Park KE, Loya A, Duvic M. Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: a national database study. J Am Acad Dermatol. 2020, 83:1786-9. 10.1016\/j.jaad.2020.03.101","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-343467","article-title":"Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts","volume":"118","author":"Blau O","year":"2011","unstructured":"Blau O, Baldus CD, Hofmann WK, et al.. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood. 2011, 118:5583-92. 10.1182\/blood-2011-03-343467","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259381-blastic-plasmacytoid-dendritic-cell-neoplasm-developed-in-chronic-myeloid-leukemia-in-molecular-remission-during-a-four-year-treatment-free-interval-after-six-years-of-dasatinib-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T12:13:28Z","timestamp":1717848808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259381-blastic-plasmacytoid-dendritic-cell-neoplasm-developed-in-chronic-myeloid-leukemia-in-molecular-remission-during-a-four-year-treatment-free-interval-after-six-years-of-dasatinib-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.61944","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,8]]}}}